Mutant isocitrate dehydrogenase 1 (IDH1) inhibitor synergistically prolongs animal survival with standard therapies in patient-derived IDH1 mutant glioma xenograft mouse models

被引:0
|
作者
Kogiso, Mari
Qi, Lin
Zhang, Huiyuan
Braun, Frank K.
Du, Yuchen
Huang, Yulun
Lindsay, Holly
Zhao, Sibo
Injac, Sarah G. G.
Liu, Zhen
Baxter, Patricia A.
Su, Jack M.
Perlaky, Laszlo
Parsons, D. Williams
Chintagumpala, Murali
Adesina, Adekunle
Wang, Jialiang
Song, Yongcheng
Li, Xiao-Nan
机构
关键词
D O I
10.1158/1538-7445.AM2017-4031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4031
引用
收藏
页数:2
相关论文
共 50 条
  • [1] MUTANT ISOCITRATE DEHYDROGENASE 1 (IDH1) INHIBITOR SYC-435 SYNERGISTICALLY PROLONGS ANIMAL SURVIVAL WITH STANDARD THERAPIES IN PATIENT-DERIVED IDH1 MUTANT GLIOMA XENOGRAFT MOUSE MODELS
    Kogiso, Mari
    Qi, Lin
    Zhang, Huiyuan
    Braun, Frank
    Du, Yuchen
    Huang, Yulun
    Lindsay, Holly
    Zhao, Sibo
    Injac, Sarah
    Liu, Zhen
    Baxter, Patricia
    Su, Jack
    Perlaky, Laszlo
    Parsons, D. Will
    Chintagumpala, Murali
    Adesina, Adekunle
    Wang, Jialiang
    Song, Yongcheng
    Li, Xiao-Nan
    NEURO-ONCOLOGY, 2017, 19 : 74 - 74
  • [2] THERAPEUTIC EFFICACY OF MUTANT ISOCITRATE DEHYDROGENASE 1 (IDH1) INHIBITOR SYC-435 WITH STANDARD THERAPY IN PATIENT-DERIVED IDH1 MUTANT GLIOMA XENOGRAFT MOUSE MODELS
    Kogiso, Mari
    Qi, Lin
    Zhang, Huiyuan
    Braun, Frank
    Du, Yuchen
    Huang, Lei
    Guo, Lei
    Huang, Yulun
    Lindsay, Holly B.
    Zhao, Sibo
    Injac, Sarah
    Baxter, Patricia
    Su, Jack
    Perlaky, Laszlo
    Parsons, Williams
    Chintagumpala, Murali
    Adekunle, Adesina
    Wang, Jialiang
    Song, Yongcheng
    Li, Xiao-Nan
    NEURO-ONCOLOGY, 2019, 21 : 91 - 92
  • [3] The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient derived xenograft (PDX) model
    Machida, Yukino
    Ogawara, Yoko
    Ichimura, Koichi
    Matsunaga, Hironori
    Takahiko, Seki
    Araki, Kazushi
    Kitabayashi, Issay
    CANCER RESEARCH, 2016, 76
  • [4] REPURPOSING THERAPEUTICS IN PATIENT-DERIVED GLIOMAS AND AN IDH1 MUTANT GLIOMA MODEL
    Schmidt, Christin
    Chen, Steven
    IIkhanizadeh, Shirin
    Sabelstrom, Hanna
    Yuan, Edith
    Ding, Andy
    Weiss, William
    Berger, Mitchel S.
    Arkin, Michelle
    Persson, Anders
    NEURO-ONCOLOGY, 2017, 19 : 84 - 85
  • [5] IDH-mutant glioma: A new IDH1 inhibitor moves forward
    Miller, Julie J.
    Arrillaga-Romany, Isabel
    NEURO-ONCOLOGY, 2023, 25 (02) : 337 - 338
  • [6] Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1
    Davis, Mindy I.
    Gross, Stefan
    Shen, Min
    Straley, Kimberly S.
    Pragani, Rajan
    Lea, Wendy A.
    Popovici-Muller, Janeta
    DeLaBarre, Byron
    Artin, Erin
    Thorne, Natasha
    Auld, Douglas S.
    Li, Zhuyin
    Dang, Lenny
    Boxer, Matthew B.
    Simeonov, Anton
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (20) : 13717 - 13725
  • [7] Mutant IDH1 and seizures in patients with glioma
    Chen, Hao
    Judkins, Jonathon
    Thomas, Cheddhi
    Wu, Meijing
    Khoury, Laith
    Benjamin, Carolina G.
    Pacione, Donato
    Golfinos, John G.
    Kumthekar, Priya
    Ghamsari, Farhad
    Chen, Li
    Lein, Pamela
    Chetkovich, Dane M.
    Snuderl, Matija
    Horbinski, Craig
    NEUROLOGY, 2017, 88 (19) : 1805 - 1813
  • [8] Textiloma resembling anaplastic progression of an isocitrate dehydrogenase 1 (IDH1) mutant, low grade glioma
    Mark Daniel Anderson
    Aditya Raghunathan
    Mark R. Gilbert
    Journal of Neuro-Oncology, 2013, 111 : 377 - 379
  • [9] Textiloma resembling anaplastic progression of an isocitrate dehydrogenase 1 (IDH1) mutant, low grade glioma
    Anderson, Mark Daniel
    Raghunathan, Aditya
    Gilbert, Mark R.
    JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (03) : 377 - 379
  • [10] THE KETOGENIC DIET IS INEFFECTIVE IN PRECLINICAL MODELS OF IDH1 WILD-TYPE AND IDH1 MUTANT GLIOMA
    Javier, Rodrigo
    Horbinski, Craig
    NEURO-ONCOLOGY, 2021, 23 : 208 - 208